BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2024 10:06:34 AM | Browse: 103 | Download: 212
Publication Name World Journal of Virology
Manuscript ID 92521
Country Bulgaria
Received
2024-01-28 17:21
Peer-Review Started
2024-01-28 17:21
To Make the First Decision
Return for Revision
2024-03-05 04:50
Revised
2024-04-02 13:05
Second Decision
2024-04-11 02:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-04-11 07:31
Articles in Press
2024-04-11 07:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-05-27 15:42
Publish the Manuscript Online
2024-06-24 10:06
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Review
Article Title Harnessing immunity: Immunomodulatory therapies in COVID-19
Manuscript Source Invited Manuscript
All Author List Tsvetelina Velikova, Hristo Valkov, Anita Aleksandrova, Monika Peshevska-Sekulovska, Metodija Sekulovski and Russka Shumnalieva
ORCID
Author(s) ORCID Number
Hristo Valkov http://orcid.org/0000-0003-3001-3278
Metodija Sekulovski http://orcid.org/0000-0001-8374-7756
Russka Shumnalieva http://orcid.org/0000-0003-2321-6536
Funding Agency and Grant Number
Funding Agency Grant Number
the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria BG-RRP-2.004-0008
Corresponding Author Russka Shumnalieva, MD, PhD, Adjunct Associate Professor, Department of Rheumatology, Clinic of Rheumatology, University Hospital "St. Ivan Rilski", Medical University-Sofia, Urvich Street 13, Sofia 1612, Bulgaria. rshumnalieva@yahoo.com
Key Words Immunomodulation; COVID-19; Severe acute respiratory syndrome coronavirus 2; Immunotherapy; Antiviral immune response; Cytokine storm; Adaptive immunity; Therapeutic strategies; Immune modulators; Viral infection; Host immune response
Core Tip Effective management of coronavirus disease 2019 (COVID-19) requires a nuanced approach that harnesses the host’s immune response Immunomodulatory therapies play a pivotal role in fine-tuning the immune system, striking a balance between defense and avoiding excessive inflammation. In line with this, increased precision in targeting specific immune pathways, alongside personalized treatment strategies, holds promise in optimizing outcomes for COVID-19 patients. This paper explores the evolving landscape of immunomodulation, emphasizing its potential as a crucial component in the therapeutic arsenal against the virus.
Publish Date 2024-06-24 10:06
Citation <p>Velikova T, Valkov H, Aleksandrova A, Peshevska-Sekulovska M, Sekulovski M, Shumnalieva R. Harnessing immunity: Immunomodulatory therapies in COVID-19. <i>World J Virol</i> 2024; 13(2): 92521</p>
URL https://www.wjgnet.com/2220-3249/full/v13/i2/92521.htm
DOI https://dx.doi.org/10.5501/wjv.v13.i2.92521
Full Article (PDF) WJV-13-92521-with-cover.pdf
Manuscript File 92521_Auto_Edited-YJP.docx
Answering Reviewers 92521-answering-reviewers.pdf
Audio Core Tip 92521-audio.mp3
Conflict-of-Interest Disclosure Form 92521-conflict-of-interest-statement.pdf
Copyright License Agreement 92521-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 92521-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 92521-non-native-speakers.pdf
Peer-review Report 92521-peer-reviews.pdf
Scientific Misconduct Check 92521-scientific-misconduct-check.png
Scientific Editor Work List 92521-scientific-editor-work-list.pdf
CrossCheck Report 92521-crosscheck-report.png
CrossCheck Report 92521-crosscheck-report.pdf